Objectives:
1. Identify the different subtypes and prognostic features of CLL
2.Discuss current and evolving indications for treatment
3. Review the literature on up-front chemoimmunotherapy
Session date:
11/28/2016 - 12:00pm to 1:00pm CST
Location:
UCMC
KCBD
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Andrew Hantel & Michael Jelinek